Innovation

2 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 34 times.

Year	Filings
2019	1
2020	1
2021	2
2022	2
2023	2
2024	1

Investor mix

5 investors on record; lead investors include F-Prime Capital, Orbimed; 3 have since exited.

Investor type	Count	Share
Venture capital	4	80%
Private equity	1	20%